Canada Gazette, Part I, Volume 154, Number 48: GOVERNMENT NOTICES

November 28, 2020

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 20405

Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment and the Minister of Health have assessed information in their possession in respect of the substance graphene, Chemical Abstracts Service Registry Number 1034343-98-0, under section 83 of the Canadian Environmental Protection Act, 1999;

Whereas the substance is not specified on the Domestic Substances List;

And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Act,

Therefore, the Minister of the Environment indicates, pursuant to section 85 of the Canadian Environmental Protection Act, 1999, that subsection 81(4) of that act applies with respect to the substance in accordance with the Annex.

The Honourable Jonathan Wilkinson
Minister of the Environment

ANNEX

Information Requirements

(Section 85 of the Canadian Environmental Protection Act, 1999)

1. The following definition applies in this notice:

“substance”
means the substance graphene, Chemical Abstracts Service Registry Number 1034343-98-0.

2. (1) If the substance meets the characteristics mentioned in subsection 3(1), a significant new activity is

(2) If the substance meets the characteristics mentioned in subsection 3(2), a significant new activity is any use involving the substance in a quantity that

3. (1) For the purposes of subsection 2(1), the substance must have the following characteristics:

(2) For the purposes of subsection 2(2), the substance must have at least one of the following characteristics:

4. Despite section 2, a use of the substance is not a significant new activity if the substance is used

5. For each proposed significant new activity, the following information must be provided to the Minister of the Environment at least 90 days before the day on which the activity begins:

6. (1) The test data and the test report described in subparagraphs 5(i)(iii), (k)(iii), (iv) and (l)(iii) must be developed in accordance with the practices described in the OECD Principles of Good Laboratory Practice set out in Annex II of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals, adopted on May 12, 1981, that are current at the time the test data are developed.

(2) Furthermore, all tests regarding the substance must be conducted in accordance with the principles described in the Guidance on Sample Preparation and Dosimetry for the Safety Testing of Manufactured Nanomaterials (OECD Series on the Safety of Manufactured Nanomaterials, No. 36) that is current at the time the test data are developed.

7. The information referred to in paragraphs 5(c) and (d) must be obtained in accordance with the principles described in the Report of the OECD Expert Meeting on the Physical Chemical Properties of Manufactured Nanomaterials and Test Guidelines (OECD Series on the Safety of Manufactured Nanomaterials, report No. 41), that are current at the time the test data are developed.

8. The information in item 5 will be assessed within 90 days after the day on which it is received by the Minister of the Environment.

Transitional provisions

9. Despite subsection 2(1), in the period between the date of publication of the present notice and November 27, 2021, if the substance meets the characteristics mentioned in subsection 3(1), a significant new activity is

10. For greater certainty, in respect of the calendar year 2021, the quantity of substance that is used before November 28 of that calendar year is not considered for the purposes of subsection 2(1).

EXPLANATORY NOTE

(This explanatory note is not part of the Significant New Activity Notice.)

Description

This Significant New Activity (SNAc) Notice is a legal instrument adopted by the Minister of the Environment pursuant to section 85 of the Canadian Environmental Protection Act, 1999 (the Act) to apply the SNAc provisions of that Act to the substance graphene, Chemical Abstracts Service Registry Number 1034343-98-0. The Notice is now in force and it is a binding law. It is therefore mandatory for a person who intends to use the substance for a significant new activity as defined in the Notice to meet all the applicable requirements set out the Notice.

A SNAc Notice does not constitute an endorsement from the Minister of the Environment, the Department of the Environment or the Government of Canada of the substance to which it relates, nor does it constitute an exemption from any other laws or regulations that are in force in Canada and that may apply to this substance or activities involving the substance.

Applicability of the Significant New Activity Notice

The Notice requires that any person (individual or corporation) engaging in a significant new activity in relation to the substance graphene, Chemical Abstracts Service Registry Number 1034343-98-0, submit a Significant New Activity notification (SNAN) containing all of the information prescribed in the Notice at least 90 days prior to using the substance for the significant new activity.

In order to address the human toxicity concerns, the Notice requires notification in relation to the use of the substance, with the characteristics mentioned in the Notice, in the manufacture of consumer products or cosmetics that are applied as a spray, mist or aerosol, when the substance is present in a concentration greater than or equal to 1% by weight. The Notice also requires notification in relation to the distribution for sale of consumer products or cosmetics that are applied as a spray, mist or aerosol when the substance, with the characteristics mentioned in the Notice, is present in a concentration greater than or equal to 1% by weight and when the total quantity of the substance involved is more than 10 kg in a calendar year. For example, notification is required if a person plans to manufacture an aerosol hair sprays where the concentration of the substance, with the characteristics mentioned in the Notice, in the hair spray is 1.5% by weight.

In order to address environmental and human toxicity concerns, notification is required for any use of the substance in Canada involving more than 100 kg of the substance in a calendar year and when the substance has at least one of the characteristics mentioned in the notice. For example, notification is required if a person plans to use 101 kg in a calendar year of the substance with 16 atomic layers.

A SNAN is required 90 days before the use of the substance in a significant new activity.

Activities not subject to the Notice

Uses of the substance that are regulated under the Acts of Parliament listed in Schedule 2 of the Act, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act are excluded from the Notice. The Notice also does not apply to transient reaction intermediates, impurities, contaminants, partially unreacted materials, or in some circumstances to items such as, but not limited to, wastes, mixtures, or manufactured items. However, it should be noted that individual components of a mixture may be subject to notification under the provisions of the Act. See subsection 81(6) and section 3 of the Act, and section 3 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers for additional information.

Activities involving the use of the substance as a research and development substance or a site-limited intermediate or an export-only product are excluded from the Notice. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers).

Information to be submitted

The Notice sets out the information that must be provided to the Minister 90 days before the day on which the substance graphene, Chemical Abstracts Service Registry Number 1034343-98-0, is used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct risk assessments within 90 days after the complete information is received.

The assessment of the substance identified concerns associated with potential activities involving use of the substance in consumer products or cosmetics that are applied as a spray, mist or aerosol, and with activities involving the substance at the nanoscale. The Significant New Activity Notice is issued to gather information to ensure that the substance will undergo further assessment before significant new activities are undertaken.

The information requirements in the Notice relate to general information in respect of the substance, details surrounding its use, exposure information, and toxicity to human health and the environment. Some of the information requirements reference the New Substances Notification Regulations (Chemicals and Polymers).

Additional guidance on preparing a SNAN can be found in section 1.3 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.

Transitional provision

A transitional provision is included in the Notice to facilitate compliance by persons who may already have imported or manufactured up to 100 kg of the substance and started activities with it in concentrations that are greater than or equal 1% by weight in a consumer product or cosmetic. The Notice comes into force immediately.

However, if the substance is used in the manufacture or the distribution for sale of a consumer product as defined in the Canada Consumer Product Safety Act or a cosmetic as defined in the Food and Drugs Act, in a concentration that is greater than or equal to 1% by weight, a quantity of less than 100 kg may be used for the period between the publication of the Notice and November 27, 2021. On November 28, 2021, the threshold will be lowered.

The transitional provisions do not apply to activities involving the substance specified in subsection 2(2) of the Notice.

Compliance

When assessing whether or not a substance is subject to SNAc provisions, a person is expected to make use of information in their possession or to which they may reasonably have access. This means information in any of the notifier’s offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information and the relevant Safety Data Sheets (SDSs), formerly “Material Safety Data Sheets” (MSDSs). More details are contained in the Regulations Amending the New Substances Notification Regulations (Chemicals and Polymers) and the Export of Substances on the Export Control List Regulations for reference to this amendment.

Although an SDS is an important source of information on the composition of a product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all product ingredients that may be subject to a SNAc notice due to human health or the environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.

If any information becomes available that reasonably supports the conclusion that the substance is toxic or capable of becoming toxic, the person who is in possession of or that has knowledge of the information and is involved in activities with the substance is obligated, under section 70 of the Act, to provide that information to the Minister without delay.

A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession or control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if their activities were covered by an original SNAN submitted by the person from whom they obtained the substance. The Substances Management Advisory Note “(ARCHIVED) Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999” provides more detail on this subject.

Under section 86 of the Act, any person who transfers the physical possession or control of a substance subject to a SNAc notice must notify all persons to whom the physical possession or control is transferred of the obligation to comply with the notice, including the obligation to notify the Minister of any SNAc and to provide all the required information outlined above.

A pre-notification consultation (PNC) is recommended for notifiers who wish to consult with the program during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.

For further information, please contact the Substances Management Information Line (eccc.substances.eccc@canada.ca (email), 1‑800‑567‑1999 [toll-free in Canada], and 819‑938‑3232 [outside of Canada]).

The Act is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act. In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for living organisms (subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Whereas, any person who proposes to import or manufacture a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(1) of the Canadian Environmental Protection Act, 1999; and

Whereas, a person may, pursuant to subsection 106(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 106(1) of the Canadian Environmental Protection Act, 1999 to be waived.

Therefore, notice is hereby given, pursuant to subsection 106(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived some requirements to provide information in accordance with the following annex pursuant to subsection 106(8) of that Act.

Thomas Kruidenier
Acting Executive Director
Program Development and Engagement Division
On behalf of the Minister of the Environment

ANNEX

Waiver of information requirements
(Subsection 106(9) of the Canadian Environmental Protection Act, 1999)
Person to whom a waiver was granted Information concerning a living organism in relation to which a waiver was granted
Adaptimmune LLC Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
Data from tests of antibiotic susceptibility
BioVectra Inc. Data from tests of antibiotic susceptibility
Celgene Inc. Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed (2) table b1 note 1
Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed (2)
Data from tests of antibiotic susceptibility (2)
Merck Canada Inc. Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
Data from tests of antibiotic susceptibility
Oncorus, Inc. Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
Pfizer Canada Inc. Data from tests to determine the effects of the living organism on aquatic plant, invertebrate, and vertebrate species likely to be exposed
Data from tests to determine the effects of the living organism on terrestrial plant, invertebrate, and vertebrate species likely to be exposed
Data from tests of antibiotic susceptibility

Table b1 note(s)

Table b1 note 1

The number in brackets indicates the number of times that the information requirement in the second column was waived for the person.

Return to table b1 note 1 referrer

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by the Minister of the Environment in consultation with the Minister of Health. Every year an average of 500 regulatory declarations are submitted for chemicals, polymers and living organisms under subsections 81(1), (3) and (4) and 106(1), (3) and (4) of the Canadian Environmental Protection Act, 1999 and around 100 waivers are granted yearly for chemicals, polymers and living organisms under subsections 81(8) and 106(8) of the Canadian Environmental Protection Act, 1999.

For more information, please see the waivers web page on the New Substances website.

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTRAL POTECTION ACT, 1999

Waiver of information requirements for substances (subsection 81(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(1) of the Canadian Environmental Protection Act, 1999; and

Whereas a person may, pursuant to subsection 81(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 81(1) of the Canadian Environmental Protection Act, 1999 to be waived.

Therefore, notice is hereby given, pursuant to subsection 81(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived some requirements to provide information pursuant to subsection 81(8) of that Act and in accordance with the following annex.

Thomas Kruidenier
Acting Executive Director
Program Development and Engagement Division
On behalf of the Minister of the Environment

ANNEX

Waiver of information requirements
(Subsection 81(9) of the Canadian Environmental Protection Act, 1999)
Person to whom a waiver was granted Information concerning a substance in relation to which a waiver was granted
AstraZeneca Canada Inc. Data in respect of vapour pressure
Data in respect of octanol/water partition coefficient
Data from a ready biodegradation test
Data from an acute toxicity test for the most sensitive species: fish, daphnia or algae
BASF Canada Inc. Data in respect of hydrolysis as a function of pH
Eastman Chemical Co. Data in respect of density
Lubrizol Canada Limited Data in respect of hydrolysis as a function of pH
Data from an in vivo mammalian mutagenicity test for chromosomal aberrations or gene mutations
NanoXplore Inc. Data in respect of boiling point
Data in respect of vapour pressure
Data in respect of octanol/water partition coefficient
Nouryon Functional Chemicals LLC Data in respect of boiling point
Data from an in vivo mammalian mutagenicity test for chromosomal aberrations or gene mutations
Novozymes North America Data in respect of melting point
Data in respect of boiling point
Data in respect of density
Data in respect of vapour pressure
Data in respect of water solubility
Data in respect of octanol/water partition coefficient

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by the Minister of the Environment in consultation with the Minister of Health. Every year an average of 500 regulatory declarations are submitted for chemicals, polymers and living organisms under subsections 81(1), (3) and (4) and 106(1), (3) and (4) of the Canadian Environmental Protection Act, 1999 and around 100 waivers are granted yearly for chemicals, polymers and living organisms under subsections 81(8) and 106(8) of the Canadian Environmental Protection Act, 1999.

For more information, please see the waivers web page on the New Substances website.

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Proposed Guidelines for Canadian Drinking Water Quality for Bromoxynil

Pursuant to subsection 55(3) of the Canadian Environmental Protection Act, 1999, the Minister of Health hereby gives notice of proposed Guidelines for Canadian Drinking Water Quality for Bromoxynil. The proposed guideline document is available for comment from November 28, 2020, to January 27, 2021, on the Health Canada consultation webpage. Any person may, within 60 days after publication of this notice, file with the Minister of Health written comments on the proposed document. Comments must be sent by email at HC.water-eau.SC@canada.ca, or by regular mail to the Water and Air Quality Bureau, Health Canada, 269 Laurier Avenue West, A.L. 4903D, Ottawa, Ontario K1A 0K9.

November 28, 2020

David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health

ANNEX

Proposed guideline

A maximum acceptable concentration (MAC) of 0.03 mg/L (30 µg/L) is proposed for bromoxynil in drinking water.

Executive summary

This guideline technical document was prepared in collaboration with the Federal-Provincial-Territorial Committee on Drinking Water and is based on assessments of bromoxynil completed by Health Canada’s Pest Management Regulatory Agency and supporting documents.

Exposure

Bromoxynil is a registered herbicide used to control broadleaf weeds in food and feed crops. In 2017 (the most recent year for which data are available), more than 1 million kilograms of bromoxynil were sold in Canada. Bromoxynil may be released into the environment as surface run-off, through spray drift or while adsorbed to dust particles.

Canadian data indicate that bromoxynil is not commonly found in source or drinking water but may be found at low levels in source and drinking water in agricultural areas where it is applied. Bromoxynil is rarely detected in foods.

Health effects

Animal studies indicate that bromoxynil primarily targets the liver. At higher doses, bromoxynil has been found to cause developmental effects (skeletal effects, decreased pup weight) but no reproductive effects. There are no human studies on the effects of bromoxynil on the liver. The proposed MAC of 0.03 mg/L (30 µg/L) is based on an increase in clinical signs (i.e. effects founded on actual observation as distinguished from theoretical or experimental effects; panting, salivation, liquid feces, pale gums) and liver weight, as well as decreases in body weight and body weight gain observed in a one-year dog study.

Analytical and treatment considerations

The establishment of drinking water guidelines takes into consideration the ability to both measure the contaminant and remove it from drinking water supplies. Several analytical methods are available for measuring bromoxynil in water at concentrations well below the proposed MAC.

At the municipal level, there is limited information on the efficiency of treatment technologies to remove bromoxynil from drinking water. Oxidation, advanced oxidation processes, and biofiltration achieved a wide range of removals. Activated carbon adsorption and membrane processes are expected to be effective. Although bromoxynil may be removed using oxidation, utilities should be aware of the potential formation of degradation by-products. Pilot- and/or bench-scale testing are recommended prior to full-scale implementation.

For bromoxynil removal at a small system or household level, for example when the drinking water supply is from a private well, a residential drinking water treatment unit may be an option. Although there are no treatment units currently certified for the removal of bromoxynil from drinking water, technologies that are expected to be effective include adsorption (activated carbon) and reverse osmosis. When using such a treatment unit, it is important to send samples of water entering and leaving the treatment unit to an accredited laboratory for analysis to ensure that adequate bromoxynil removal is occurring.

Application of the guideline

Note: Specific guidance related to the implementation of drinking water guidelines should be obtained from the appropriate drinking water authority in the affected jurisdiction.

The proposed guideline for bromoxynil is protective against health effects from exposure to bromoxynil in drinking water over a lifetime. Any exceedance of the proposed MAC should be investigated and followed by the appropriate corrective actions if required. For exceedances in source water where there is no treatment in place, additional monitoring to confirm the exceedance should be conducted. If it is confirmed that source water bromoxynil concentrations are above the proposed MAC, then an investigation to determine the most appropriate way to reduce exposure to bromoxynil should be conducted. This may include use of an alternate water supply or installation of treatment. Where treatment is already in place and an exceedance occurs, an investigation should be conducted to verify treatment and determine if adjustments are needed to lower the treated water concentration below the proposed MAC.

International considerations

Other national and international organizations have drinking water guidelines, standards and/or guidance values for bromoxynil in drinking water. Variations in these values can be attributed to the age of the assessments or to differing policies and approaches, including the choice of key study and the use of different consumption rates, body weights and source allocation factors.

Australia’s National Health and Medical Research Council has established a guideline value of 0.01 mg/L (10 μg/L) for bromoxynil in drinking water based on decreased body weights in a one-year dog study. The United States Environmental Protection Agency has not set a regulatory value for bromoxynil in drinking water. Similarly, the World Health Organization does not have a guideline for bromoxynil.

The European Union (EU) does not have a specific parametric value for individual pesticides. Instead, the EU has a value of 0.1 μg/L for any individual (single) pesticide, and a value of 0.5 μg/L for total pesticides found in drinking water. In establishing these values, the EU did not consider the science related to each pesticide, such as health effects. Instead, the values are based on a policy decision to keep pesticides out of drinking water.

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Filing of claims for exemption

A supplier can file a claim for exemption under the Hazardous Materials Information Review Act (HMIRA) with Health Canada from having to disclose information under the Hazardous Products Act (HPA) and Hazardous Products Regulations (HPR) that they consider to be confidential business information (CBI) on a safety data sheet (SDS) or label associated with a hazardous product.

An employer can also file a claim for exemption under the HMIRA with Health Canada from having to disclose information under the Canada Labour Code or the provisions of the Accord Act that they consider to be CBI on an SDS or label associated with a hazardous product.

Notice is hereby given of the filing of claims for exemption under the HMIRA listed in the table below.

Lynn Berndt-Weis
Director
Workplace Hazardous Materials Bureau
Consumer and Hazardous Products Safety Directorate
Healthy Environments and Consumer Safety Branch

Claimant Product Identifier Subject of the Claim for Exemption Registry Number
Momentive Performance Materials Silquest* A-2387 C.i. and C. of one ingredient 03388823
Afton Chemical Company HiTEC® 4142M Fuel Additive C.i. of one ingredient 03389456
3M Canada Company 3M™ Polyurethane Sealant 540 (Various Colours) C. of two ingredients 03389565
Secure Energy Services SECURE MO-8910 C.i. and C. of one ingredient
C. of one ingredient		 03389735
King Industries, Inc. NA-SUL® CA-1122 C.i. and C. of one ingredient
C. of one ingredient		 03389740
ChampionX Canada ULC ACPC12261B C.i. and C. of two ingredients 03390400
King Industries, Inc. K-KAT® XK-682 C.i. and C. of one ingredient 03390557
Pacer Chemical Inc. Prosolve 120 C.i. and C. of three ingredients 03390558
Pacer Chemical Inc. Prosolve 110 C.i. and C. of two ingredients 03390559
Advancing Chemistry Inc. W-SPA-HT C.i. and C. of eight ingredients 03390717
Produits Environnementaux Greensolv inc. WHEELSTRIP PREMIUM C.i. and C. of four ingredients 03390868
Afton Chemical Corporation HiTEC® 013 Performance Additive C.i. of two ingredients 03390948
Advancing Chemistry Inc. W-SPA C.i. and C. of five ingredients 03390949
The Lubrizol Corporation LUBRIZOL® 9688 C.i. of four ingredients 03391104
Chemtrade Logistics Inc. Pass C Plus (+) C.i. of one ingredient 03391398
Allnex Canada Inc., c/o Goodmans, LLP EBECRYL® 3214 radiation curing resins C.i. of one ingredient 03391605
Momentive Performance Materials Niax* silicone L-6164 C.i. and C. of one ingredient 03391606
Shell Catalysts& Technologies CENTERA GT Catalyst DN-3655 C.i. of two ingredients 03391607
W-Tech Technologies Ltd. Vanfloc MRC 4500 C.i. of one ingredient 03391761
W-Tech Technologies Ltd. Vanmist 210 C.i. of two ingredients 03391762
3M Canada Company 3M™ Scotch-Weld™ Low Odour Acrylic Adhesive 8805NS Green, Part B C. of one ingredient 03391763
3M Canada Company 3M™ Scotch-Weld™ Epoxy Adhesive 110 Gray, Part A C. of one ingredient 03391764

Note: C.i. = chemical identity and C. = concentration

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments

November 19, 2020

Diane Bélanger
Official Documents Registrar

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

Royal Bank of Canada — Exemption

Notice is hereby given, pursuant to subsection 156.05(4) of the Bank Act (the “Act”), that the management of Royal Bank of Canada (“RBC”) has, pursuant to subsection 156.05(3) of the Act, been exempted from the requirement of paragraph 156.05(1)(a) of the Act to send the prescribed management proxy circular to each shareholder whose proxy is solicited for the annual meeting of shareholders to be held on or about April 8, 2021, and any subsequent annual and/or special meetings.

The exemption is granted on the basis that RBC makes the prescribed management proxy circular accessible, as well as sends a notice thereof, in accordance with National Instrument 51-102 Continuous Disclosure Obligations and National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer, to each shareholder whose proxy is solicited.

This exemption was granted on November 6, 2020.

November 28, 2020

Jeremy Rudin
Superintendent of Financial Institutions

PRIVY COUNCIL OFFICE

Appointment opportunitie

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.

Governor in Council appointment opportunities
Position Organization Closing date
Member Atlantic Pilotage Authority Canada  
President and Chief Executive Officer Atomic Energy of Canada Limited  
Member Buffalo and Fort Erie Public Bridge Authority  
Director Business Development Bank of Canada  
Director — Board Risk Committee Chairperson Business Development Bank of Canada  
President and Chief Executive Officer Canada Development Investment Corporation  
Commissioner for Employers Canada Employment Insurance Commission  
President and Chief Executive Officer Canada Lands Company Limited  
President Canada Mortgage and Housing Corporation  
Member of the Board of Directors Canada Post  
Member
(Federal)		 Canada–Newfoundland and Labrador Offshore Petroleum Board  
President Canadian Commercial Corporation  
Member Canadian Cultural Property Export Review Board  
Commissioner
(full-time), Commissioner (part-time)		 Canadian Energy Regulator  
Director Canadian Energy Regulator  
Chief Commissioner Canadian Grain Commission  
Commissioner Canadian Grain Commission  
Member Canadian Human Rights Tribunal  
Chairperson Canadian International Trade Tribunal  
Chairperson Canadian Museum of History  
Director Canadian Museum of History  
Permanent Member Canadian Nuclear Safety Commission  
Chairperson Canadian Transportation Agency  
Temporary Member Canadian Transportation Agency  
Chief Administrator Courts Administration Service  
Director Farm Credit Canada  
Chairperson Federal Public Sector Labour Relations and Employment Board  
Vice-Chairperson Federal Public Sector Labour Relations and Employment Board  
Director Freshwater Fish Marketing Corporation  
Chairperson Great Lakes Pilotage Authority Canada  
Director
(Federal)		 Hamilton-Oshawa Port Authority  
Member, Northwest Territories Historic Sites and Monuments Board of Canada  
Assistant Deputy Chairperson Immigration and Refugee Board of Canada  
Commissioner Impact Assessment Agency of Canada  
Member
(appointment to roster)		 International Trade and International Investment Dispute Settlement Bodies  
Chairperson The Jacques Cartier and Champlain Bridges Incorporated  
Chairperson Laurentian Pilotage Authority Canada  
Chairperson Military Police Complaints Commission of Canada  
Member Military Police Complaints Commission of Canada  
Director
(Federal)		 Nanaimo Port Authority  
Member National Arts Centre Corporation  
Secretary National Battlefields Commission  
Member National Seniors Council  
Member Natural Sciences and Engineering Research Council of Canada  
Veterans’ Ombudsman Office of the Veterans Ombudsman  
Member Payments in Lieu of Taxes Dispute Advisory Panel  
Director Public Sector Pension Investment Board  
Commissioner Roosevelt Campobello International Park Commission  
Member Social Sciences and Humanities Research Council of Canada  
President Social Sciences and Humanities Research Council of Canada  
Registrar Supreme Court of Canada  
Member Telefilm Canada  
Chairperson and Member Transportation Appeal Tribunal of Canada  
Member Transportation Appeal Tribunal of Canada  
Vice-Chairperson Transportation Appeal Tribunal of Canada  

TREASURY BOARD SECRETARIAT

MEMBERS OF PARLIAMENT RETIRING ALLOWANCES ACT

2021, 2022 and 2023 member contribution rates for the Members of Parliament pension plan

In accordance with subsection 2.7(10) of the Members of Parliament Retiring Allowances Act, the contribution rates, footnote 1 for calendar years 2021, 2022 and 2023, fixed under subsection 2.7(1) of the Act, are as follows:

1. Contribution rates prior to reaching the 75% maximum pension accrual

Table 1: Members of Parliament Retiring Allowances (MPRA) Account
Calendar
Year		 Under Age 71 Ages 71 and Above Combined
Below YMPE table b5 note a YMPE to MPE table b5 note b Above MPE Combined
2021 13.42 17.13 0.00 13.40 0.00 12.47
2022 13.62 17.39 0.00 13.59 0.00 12.47
2023 13.67 17.45 0.00 13.66 0.00 12.47

Table b5 note(s)

Table b5 note a

YMPE: Year’s Maximum Pensionable Earnings are the maximum earnings for which contributions can be made to the Canada Pension Plan or the Quebec Pension Plan during the year. For 2021, the YMPE is $61,600. The 2022 and 2023 YMPEs are not available yet.

Return to table b5 note a referrer

Table b5 note b

MPE: Maximum Pensionable Earnings are calculated based on the defined benefit limit established by the Income Tax Act, which represent the maximum pensionable earnings on which pension benefits can be accrued during a calendar year. Starting January 1, 2016, the MPE takes into consideration the coordination of the retirement allowance payable with the benefits of the Canada Pension Plan or the Quebec Pension Plan. For 2021, the MPE is $170,500. The 2022 and 2023 MPEs are not available yet.

Return to table b5 note b referrer
Table 2: Members of Parliament Retirement Compensation Arrangements (MPRCA) Account
Calendar
Year		 Under Age 71 Ages 71 and Above Combined
Below MPE table b6 note a Above MPE Combined
2021 7.55 23.34 9.94 23.34 10.87
2022 7.31 23.34 9.75 23.34 10.87
2023 7.26 23.34 9.68 23.34 10.87

Table b6 note(s)

Table b6 note a

MPE: Maximum Pensionable Earnings are calculated based on the defined benefit limit established by the Income Tax Act, which represent the maximum pensionable earnings on which pension benefits can be accrued during a calendar year. Starting January 1, 2016, the MPE takes into consideration the coordination of the retirement allowance payable with the benefits of the Canada Pension Plan or the Quebec Pension Plan. For 2021, the MPE is $170,500. The 2022 and 2023 MPEs are not available yet.

Return to table b6 note a referrer
Table 3: Total for MPRA and MPRCA Accounts
Calendar
Year		 Under Age 71 Ages 71 and Above Combined
Below YMPE table b7 note a YMPE to MPE table b7 note b Above MPE Combined
2021 20.97 24.69 23.34 23.34 23.34 23.34
2022 20.94 24.70 23.34 23.34 23.34 23.34
2023 20.93 24.71 23.34 23.34 23.34 23.34

Table b7 note(s)

Table b7 note a

YMPE: Year’s Maximum Pensionable Earnings are the maximum earnings for which contributions can be made to the Canada Pension Plan or the Quebec Pension Plan during the year. For 2021, the YMPE is $61,600. The 2022 and 2023 YMPEs are not available yet.

Return to table b7 note a referrer

Table b7 note b

MPE: Maximum Pensionable Earnings are calculated based on the defined benefit limit established by the Income Tax Act, which represent the maximum pensionable earnings on which pension benefits can be accrued during a calendar year. Starting January 1, 2016, the MPE takes into consideration the coordination of the retirement allowance payable with the benefits of the Canada Pension Plan or the Quebec Pension Plan. For 2021, the MPE is $170,500. The 2022 and 2023 MPEs are not available yet.

Return to table b7 note b referrer

2. Contribution rates upon reaching the 75% maximum pension accrual

Table 4: Summary of contribution rates upon reaching the 75% maximum pension accrual
Calendar Years 2021 to 2023 MPRA Account MPRCA Account
Members under age 71 1.00% (salary up to MPE table b8 note a ) 1.00% (salary above the MPE table b8 note a )
Members 71 and above 0.00% 1.00%

Table b8 note(s)

Table b8 note a

MPE: Maximum Pensionable Earnings are calculated based on the defined benefit limit established by the Income Tax Act, which represent the maximum pensionable earnings on which pension benefits can be accrued during a calendar year. Starting January 1, 2016, the MPE takes into consideration the coordination of the retirement allowance payable with the benefits of the Canada Pension Plan or the Quebec Pension Plan. For 2021, the MPE is $170,500. The 2022 and 2023 MPEs are not available yet.

Return to table b8 note a referrer

Jean-Yves Duclos
President of the Treasury Board

BANK OF CANADA

Statement of financial position as at October 31, 2020
(Millions of dollars) Unaudited

ASSETS

Amount

Total

Cash and foreign deposits

  

6.7

Loans and receivables

Securities purchased under resale agreements

155,096.3

  

Advances to members of Payments Canada

1.0

  

Other receivables

4.7

  
   

155,102.0

Investments

Government of Canada treasury bills

69,682.9

  

Government of Canada bonds – carried at amortized cost

101,546.8

  

Government of Canada bonds – carried at fair value through profit and loss

169,267.1

  

Canada Mortgage Bonds

9,645.2

  

Other bonds

11,113.1

  

Securities lent or sold under repurchase agreements

1,793.8

  

Other securities

5,355.3

  

Shares in the Bank for International Settlements (BIS)

505.4

  
   

368,909.6
Derivatives — Indemnity agreements with the Government of Canada  

277.2

Capital assets

Property and equipment

570.4

Intangible assets

74.1

Right-of-use leased assets

46.1

 

  

690.6

Other assets

  

34.7

Total assets

  

525,020.8

LIABILITIES AND EQUITY

Amount

Total

Bank notes in circulation

  

103,601.3

Deposits

Government of Canada

106,176.2

  

Members of Payments Canada

303,453.9

  

Other deposits

9,010.4

  
   

418,640.5

Securities sold under repurchase agreements

  

1,087.0

Derivatives — Indemnity agreements with the Government of Canada

  

—

Other liabilities

  

1,094.6
   

524,423.4

Equity

Share capital

5.0

  

Statutory and special reserves

125.0

  

Investment revaluation reserve

467.4

  
   

597.4

Total Liabilities and Equity

525,020.8

I declare that the foregoing statement is correct according to the books of the Bank.

Ottawa, November 18, 2020

Coralia Bulhoes
Chief Financial Officer and Chief Accountant

I declare that the foregoing statement is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.

Ottawa, November 18, 2020

Tiff Macklem
Governor